In randomized, double-blind, multicentre trials of 3 to 6 weeks' duration (n=127-383), a significantly greater number of patients with tinea of the glabrous skin and tinea pedis receiving a topical 2%<unk>  cream once or twice daily achieved a successful mycological cure compared with recipients of a placebo cream.
Sertaconazole
Itraconazole
Ketoconazole
Efinaconazole
Posaconazole
Miconazole
Nystatin
Levoketoconazole